Clinical Trial

A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare the single-dose pharmacokinetics (PK) of casdatifan 100 mg versus four 25 mg tablets under fasting conditions in healthy adult participants, and to evaluate the effect of food on the single-dose PK of casdatifan 100 mg administered as four 25 mg tablets in healthy adult participants.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-14
minor Completion pushed: 2026-07 -> 2026-08-07 2026-08-14
critical Recruitment opened 2026-06-18
Trial Details
NCT Number NCT07641881
Lead Sponsor Arcus Biosciences, Inc.
Collaborators: Taiho Pharmaceutical Co., Ltd.
Conditions Healthy Participants
Enrollment 24 participants
Start Date 2026-05-29
Primary Completion 2026-07-03 (estimated)
Study Completion 2026-08-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-13